Haleon (HLNCF) EPS (Weighted Average and Diluted) (2021 - 2023)
Haleon (HLNCF) recorded quarterly EPS (Weighted Average and Diluted) of $0.03 in Q4 2023, down 65.13% on a QoQ basis from $0.09 in Q2 2023, and up 7.67% year-over-year from $0.03 in Q4 2022.
Haleon (HLNCF) EPS (Weighted Average and Diluted) (2021 - 2023) Analysis & Trends
Haleon has disclosed EPS (Weighted Average and Diluted) across 3 years of filings, most recently posting $0.03 for Q4 2023.
- Quarterly EPS (Weighted Average and Diluted) rose 7.67% year-over-year to $0.03 in Q4 2023, while the trailing twelve-month figure through Dec 2024 was $0.04 (up 26.89% YoY) and the FY2025 annual result came in at $0.24, up 21.54% from the prior year.
- EPS (Weighted Average and Diluted) declined to $0.03 in Q4 2023, from $0.09 in the prior quarter.
- Over five years, EPS (Weighted Average and Diluted) peaked at $0.21 in Q3 2022 and troughed at $0.03 in Q4 2022.
- A 3-year average of $0.08 and a median of $0.04 in 2021 frame the typical range for EPS (Weighted Average and Diluted).
- Annual changes were most pronounced in 2022 — EPS (Weighted Average and Diluted) retreated 28.32% — and 2023, when it climbed 7.67%.
- Tracing HLNCF's EPS (Weighted Average and Diluted) over 3 years: stood at $0.04 in 2021, then fell by 28.32% to $0.03 in 2022, then climbed by 7.67% to $0.03 in 2023.
- Business Quant data shows HLNCF's EPS (Weighted Average and Diluted) at $0.03 in Q4 2023, $0.09 in Q2 2023, and $0.03 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 0.31 |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 1.42 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 5.82 |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 0.02 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 1.91 |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 0.11 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -0.40 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.80 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -0.40 |
| 10 | Haleon | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 0.03 |
| May 3, 2023 | 0.09 |
| Dec 31, 2022 | 0.03 |
| Sep 20, 2022 | 0.21 |
| Dec 31, 2021 | 0.04 |